BPC-157 is a synthetic 15-amino-acid peptide, structurally derived from a sequence identified in gastric juice
It allows you to do the work required to heal without being limited by excessive inflammation

REDEFINE 2 Trial Type 2 Diabetes with Obesity The companion REDEFINE 2 trial, also published in 2025, enrolled 1,206 adults with type 2 diabetes and obesity or overweight, demonstrating the combinations efficacy in this more metabolically compromised population: Mean weight loss of 13.7% compared to 3.4% with placebo over 68 weeks 73.5% achieved hemoglobin A1c of 6.5% or less compared to 15.9% with placebo Greater proportions reaching multiple weight thresholds including 5%, 10%, 15%, and 20% reduction Significant glycemic improvement with mean A1c reduction demonstrating disease modification potential Favorable metabolic profile changes including improvements in blood pressure and lipids These findings established that the combination maintains substantial efficacy even in patients with the metabolic dysfunction of established type 2 diabetes, a population often showing reduced response to weight-loss interventions

In Ponte Vedra, visit Bluewater Wellness and Med Spa for your Vitamin Injections
Proper technique reduces risks like vein irritation, infection, or incorrect dosing
Improved metabolism: NAD therapy can help to improve metabolism by boosting the body's natural production of energy